📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0. (2018)

First Author: Bidmos FA

Attributed to: Imperial Confidence in Concept: ICiC5 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2018.01621

PubMed Identifier: 30061891

Publication URI: http://europepmc.org/abstract/MED/30061891

Type: Journal Article/Review

Volume: 9

Parent Publication: Frontiers in immunology

ISSN: 1664-3224